Avinger Inc (AVGR) - Total Liabilities
Based on the latest financial reports, Avinger Inc (AVGR) has total liabilities worth $9.73 Million USD as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avinger Inc - Total Liabilities Trend (2012–2023)
This chart illustrates how Avinger Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Avinger Inc to evaluate short-term liquidity relative to the company's equity base.
Avinger Inc Competitors by Total Liabilities
The table below lists competitors of Avinger Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ortin Global Limited
NSE:ORTINGLOBE
|
India | Rs34.10 Million |
|
RIDGESTONE MINING INC.
F:4U50
|
Germany | €717.46K |
|
Central China Real Estate Limited
F:AJ5
|
Germany | €103.47 Billion |
|
ProAm Explorations Corp
V:PMX
|
Canada | CA$256.39K |
|
Vastra Hamnens Restaurangdrift Ab
ST:VH
|
Sweden | Skr3.47 Million |
|
INCUVO S.A. ZY -50
F:68X
|
Germany | €2.42 Million |
|
Yida China Holdings Ltd
STU:YC2
|
Germany | €27.26 Billion |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
|
Finland | €5.58 Million |
Liability Composition Analysis (2012–2023)
This chart breaks down Avinger Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Avinger Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avinger Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avinger Inc (2012–2023)
The table below shows the annual total liabilities of Avinger Inc from 2012 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $19.97 Million | -0.38% |
| 2022-12-31 | $20.05 Million | +1.45% |
| 2021-12-31 | $19.76 Million | -1.77% |
| 2020-12-31 | $20.12 Million | +18.84% |
| 2019-12-31 | $16.93 Million | +18.90% |
| 2018-12-31 | $14.24 Million | -71.96% |
| 2017-12-31 | $50.78 Million | +2.96% |
| 2016-12-31 | $49.32 Million | +28.04% |
| 2015-12-31 | $38.52 Million | -77.16% |
| 2014-12-31 | $168.65 Million | +22.39% |
| 2013-12-31 | $137.79 Million | +32.53% |
| 2012-12-31 | $103.97 Million | -- |
About Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more